CDKN1A and breast cancer: In breast cancer cells treated by 17-beta-estradiol after radiation injury, it does not affect p53 activation but decreases cyclin E binding to p21(waf1/cip1), and downstream Rb hyperphosphorylation persists due to functional p21(waf1/cip1) inactivation, resulting in continued senescence [167].